Download Program
Click on the session name for more details about the session

Thursday, March 24, 2022

TimeProgram
02:00 PM - 04:00 PM Pre-Conference | Workshop by BiologixFerriprox® in the Management of Iron Overload
04:00 PM - 04:25 PM Industry Symposium by Novo NordiskN8-GP (turoctocog alfa pegol; Esperoct): An extended half-life recombinant factor VIII molecule for patients with haemophilia A
04:30 PM - 04:55 PM Industry Symposium by MSDAntifungal prophylaxis in high-risk patients with hematological malignancies
05:00 PM - 05:25 PM Industry Symposium by RocheDLBCL: Where do we stand in 2022?
05:30 PM - 06:25 PM Industry Symposium by NovartisASH Updates in SCD & Cardiovascular Risk in PV
06:30 PM - 06:55 PM Industry Symposium by BMS 1Management of transfusion-dependent thalassemia: Unmet needs and novel therapies
07:00 PM - 07:25 PM Industry Symposium by SandozBiosimilars for treating lymphoma : Rixathon “Rituximab Biosimilar by Sandoz”
07:30 PM - 07:55 PM Industry Symposium by SanofiThe Era of MRD Negativity and it’s impact on MM Management & Isatuximab phase 3 pivotal clinical Trial IKEMA trial
08:00 PM - 08:25 PM Industry Symposium by AstraZenecaHow to Select BTKI for your Patient?... The luxury to choose
08:30 PM - 08:55 PM Industry Symposium by BMS 2TDT.. What has changed?

Friday, March 25, 2022

TimeProgram
02:00 PM - 02:25 PM Industry Symposium by Eli LillyIndolent lymphoproliferative disease
02:30 PM - 02:55 PM Industry Symposium by AstellasADMIRAL Study: The paradigm shift for R/R FLT3 mutated AML Patients
02:55 PM - 03:00 PM Opening Remarks
03:00 PM - 04:20 PM Session 1: Myeloid Disorders
04:25 PM - 04:40 PM ALL Case Presentations
04:45 PM - 05:25 PM Q&A - Meet the Experts (Day 1)
05:30 PM - 05:55 PM Industry Symposium by StemlineBlastic Plasmacytoid Dendritic Cell Neoplasm BPDCN (Disease state, History, Diagnosis and Novel therapies)
05:55 PM - 06:20 PM Industry Symposium by Abbvie BCL2i outcomes in high-risk CLL patients

Saturday, March 26, 2022

TimeProgram
01:30 PM - 01:55 PM Industry Symposium by MSD 2The management paradigm of cHL
02:00 PM - 02:25 PM Industry Symposium by Amgen Key Highlights in Managing RRMM
02:30 PM - 02:55 PM Industry Symposium by KyowaKirinCutaneous T-Cell Lymphomas : Overview and clinical considerations
03:00 PM - 03:45 PM Session 2: Best of ASH
03:50 PM - 05:10 PM Session 3: Lymphoproliferative disorders I
05:15 PM - 06:35 PM Session 4: Lymphoproliferative disorders II
06:40 PM - 06:50 PM Challenging Case Presentation
06:50 PM - 07:10 PM Lymphoma Case Presentations
07:10 PM - 07:50 PM Q&A - Meet the Experts (Day 2)
07:55 PM - 08:20 PM Industry Symposium by Janssen 1New Horizons in CLL management
08:20 PM - 08:45 PM Industry Symposium by Takeda 1Acquired Hemophilia: The Tawam Experience
08:45 PM - 09:10 PM Industry Symposium by Takeda 2Maximizing patients outcome in Gaucher Disease

Sunday, March 27, 2022

TimeProgram
02:00 PM - 02:25 PM Industry Symposium by Janssen 2Advances in Management of Newly Diagnosed Multiple Myeloma
02:30 PM - 02:55 PM Industry Symposium by AstraZeneca 2Beyond COVID 19 Vaccination: Evusheld (tixagevimab and cilgavimab) for the Prevention of Covid-19
03:00 PM - 04:20 PM Session 5: Plasma Cell Disorders
04:25 PM - 05:25 PM Session 6: Bleeding Disorders
05:30 PM - 05:40 PM Myeloma Case Presentations
05:40 PM - 06:20 PM Q&A - Meet the Experts (Day 3)

*The scientific program is subject to change.